Keros
Keros is a biotechnology firm that researches and commercializes novel therapies for the treatment of neuromuscular disorders.
Business Model:
Revenue: $20.1M
Employees: 51-200
Industries / Tags:
Detailed Keros Information
Geographic Data
Address: 99 Hayden Avenue
City: Lexington
State: MA
Zip: 02421
Country: US
Financial Info
Stage:
series c
Raised Last:
$56M
Raised Total:$90M
Social
Metrics
2,001,453Website Global Rank
10,400Website Monthly Traffic
Twitter Followers
Description
Keros is a biotechnology firm that researches and commercializes novel therapies for the treatment of neuromuscular disorders.
Contact Phone:
+16173146297
Contact Email:
Keros went public on 4/7/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/7/2020
IPO Valuation:
$307M
Ticker Symbol:
KROS
IPO Price:
$16/share
Amount Raised:
$96M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
